ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1915

Development of an MRI-based Definition of Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study

Jean Liew1, Gabriela Rabasa2, Michael LaValley3, Jamie collins4, Joshua Stefanik5, Ali Guermazi2, Cora E. Lewis6, Michael Nevitt7, James Torner8 and David Felson2, 1Boston University School of Medicine, Boston, MA, 2Boston University, Boston, MA, 3Boston University School of Public Health, Arlington, MA, 4Brigham and Women's Hospital, Boston, MA, 5Northeastern University, Boston, MA, 6University of Alabama at Birmingham, Birmingham, AL, 7University of California at San Francisco, Orinda, CA, 8University of Iowa, Iowa City, IA

Meeting: ACR Convergence 2022

Keywords: Imaging, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Osteoarthritis – Clinical Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: MRI is becoming the OA imaging modality of choice. It allows quantification of cartilage damage, the signature pathologic feature of disease. Proposed MRI-based definitions of OA have limitations, including inconsistency across tibiofemoral (TF) versus patellofemoral (PF) compartments and the possibility of satisfying the OA definition without cartilage damage despite this being a hallmark feature of OA. A definition should not consider cartilage damage as a sole criterion as it also occurs following joint trauma in the absence of OA; and should include osteophytes, which represent a bony response to cartilage loss. Using radiographic and symptomatic/radiographic OA as gold standards, we calculated the sensitivity and specificity of MRI-based definitions of knee OA that included cartilage damage and osteophytes as required criteria and tested whether inclusion of bone marrow lesions or synovitis, features associated with pain and disease progression, improved diagnostic performance.

Methods: Participants from the Multicenter Osteoarthritis (MOST) study, a longitudinal prospective cohort of older adults with knee x-rays and MRIs at the 30-month study visit, were included in this cross-sectional analysis. Whole knee radiographic OA (ROA) was defined as Kellgren-Lawrence (KL) grade ≥2 in either the TF or PF joint. Symptomatic ROA (SxROA) was defined as ROA with frequent knee pain in the affected knee. MRI abnormalities were scored using the WORMS scale in 14 regions in the TF and PF joints, including cartilage (scored 0-6 with definite cartilage damage scored ≥2), osteophytes (0-6), and either presence of bone marrow lesions (BMLs) (0-3), or effusion/synovitis or synovitis (0-3 at 3 sites). For each feature, we chose the worst WORMS score in the knee.

We tested different combinations of MRI features, which we compared to the gold standards of prevalent ROA and SxROA. Combinations of MRI features included cartilage damage (WORMS ≥2) and osteophyte score ≥2 (alternatively, ≥3). In addition, we tested definitions that included BMLs (score ≥1 or ≥2) and synovitis (≥1 or ≥2). For each MRI OA definition, we calculated sensitivity (Sn), specificity (Sp), positive and negative predictive values (PPV and NPV) and the area under the curve (AUC). We chose the definition with highest AUC that preserved Sn ≥ 80% for ROA.

Results: We included 1185 individuals (1185 knees) (mean age 61 years, 62% female, 89% white). Of these, 316 had prevalent ROA and 83 prevalent SxROA. The best performing definitions for both ROA and SxROA required not only cartilage damage and osteophytes but either mild-moderate BMLs or synovitis (Sn 90.7%, Sp 50%, AUC 0.70 for ROA).

Conclusion: We tested MRI-based definitions for OA, that all included cartilage damage and allowed for consistency across the TF and PF compartments, against the gold standards of prevalent ROA and SxROA. We found that a definition involving cartilage damage, osteophytes, and the presence of either moderate BMLs or synovitis had the best metrics for identifying ROA and SxROA. This improves on proposed definitions that could leave cartilage out and provided inconsistent disease definitions across compartments.

Supporting image 1

Performance characteristics of potential MRI definitions for whole knee ROA, where MRI definition of OA is compared to the gold standard definition of ROA

Supporting image 2

Performance characteristics of potential MRI definitions for whole knee SxROA, where MRI definition of OA is compared to the gold standard definition of SxROA


Disclosures: J. Liew, None; G. Rabasa, None; M. LaValley, None; J. collins, None; J. Stefanik, None; A. Guermazi, AstraZeneca, Merck/MSD, Pfizer, Novartis; C. Lewis, None; M. Nevitt, None; J. Torner, None; D. Felson, None.

To cite this abstract in AMA style:

Liew J, Rabasa G, LaValley M, collins J, Stefanik J, Guermazi A, Lewis C, Nevitt M, Torner J, Felson D. Development of an MRI-based Definition of Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/development-of-an-mri-based-definition-of-knee-osteoarthritis-data-from-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-an-mri-based-definition-of-knee-osteoarthritis-data-from-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology